Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition

Wendy Mao, Ali Ghasemzadeh, Zachary T. Freeman, Aleksandar Obradovic, Matthew G. Chaimowitz, Thomas R. Nirschl, Emily McKiernan, Srinivasan Yegnasubramanian, Charles G. Drake

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences